logo
Roam Launches Business eSIM to Power Global Teams with Reliable Connectivity Across 180+ Countries

Roam Launches Business eSIM to Power Global Teams with Reliable Connectivity Across 180+ Countries

VANCOUVER, BC / ACCESS Newswire / April 21, 2025 / Roam, a decentralized open wireless network, has officially launched its Business eSIM Plan. This next-generation connectivity solution enables global teams-especially Web3 businesses-to effortlessly access seamless, scalable, global connectivity in over 180 countries, eliminating roaming fees, SIM swaps, and setup hassles. Notably, it allows businesses to reduce roaming costs by up to 80%.
This launch responds to the increasing need for seamless connectivity among remote teams and global enterprises, especially in the Web3 sector, where international collaboration is vital, and traditional mobile solutions fall short.
A New Standard for Global Roaming
Roam's Business eSIM eliminates one of the most persistent pain points for traditional companies: fragmented, expensive, and hard-to-manage mobile connectivity. Unlike telecom operators that offer fixed plans or per-country packages, Roam gives enterprises an all-in-one eSIM solution.
Roam eSIM offers global coverage in 180+ countries with a single eSIM profile. Employees can activate their eSIM instantly via the Roam App, getting online the moment they land-no SIM swaps or manual setup needed.
With an admin dashboard, companies can assign eSIMs to team members based on destination or role, set daily or monthly budget limits, and track real-time account balance. Balance never expires and can be reallocated across trips or employees, making Roam ideal for professionals and teams that are always on the move. Finance teams can export usage data in CSV format for reporting or reconciliation.
Flexible Payments & Top-Up Bonuses
Roam supports a wide range of payment options including traditional credit cards and cryptocurrencies. Businesses that choose to pay with $ROAM receive an exclusive 10% discount on their account.
On top of that, businesses enjoy up to 35% Top-up bonuses. For example, when businesses top up $500, they receive $550 in credit, and with a $2000 top-up, they get $2400 in credit.
Built for Global Workforces, Ready for the Future
Roam Business eSIM is built to meet the needs of any traditional or Web3 business with a global presence. It enables seamless connectivity without the hassle of local SIMs, manual setup, or roaming fees. With no limit on team access, organizations can scale effortlessly as their workforce grows.
As the boundaries of work, geography, and identity continue to shift, Roam is more than just a data provider-it serves as an open wireless network, supporting ecosystem collaboration, remote onboarding, and real-time operations on a global scale.
For More Information, Please Visit:
PR Contact:
ZEX PR WIRE
[email protected]
SOURCE: Roam
press release
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Solana Volume Bot Debuts New Solana Volume Booster for Instant Dexscreener Trending
Solana Volume Bot Debuts New Solana Volume Booster for Instant Dexscreener Trending

Associated Press

time32 minutes ago

  • Associated Press

Solana Volume Bot Debuts New Solana Volume Booster for Instant Dexscreener Trending

SolanaVolumeBot launches Boost Legends Volume Bot, a revolutionary Solana volume booster that transforms token visibility through intelligent buy-sell trading patterns. This advanced Solana volume bot creates natural-looking chart activity by executing multiple buy and sell orders, making tokens appear highly active and attractive to investors. MIAMI, FL / ACCESS Newswire / July 4, 2025 / Boost Legends Volume Bot today announced the official launch of its new Solana volume bot, a comprehensive automated trading platform designed specifically for the Solana blockchain ecosystem. The new Solana volume booster enables token projects to generate trading volume through automated buy and sell order execution across multiple decentralized exchanges. The company's Solana volume bot platform, accessible through the Boost Legends Volume Bot on Telegram, represents a significant development in automated trading technology for Solana-based projects. This Solana volume booster addresses growing demand from token projects seeking to establish consistent trading activity and market presence on popular tracking platforms including Dexscreener. Technical Architecture of the Solana Volume Bot Platform The Boost Legends Solana volume bot operates through sophisticated algorithmic trading systems that execute multiple buy and sell orders across various price points. The Solana volume booster connects directly to major Solana decentralized exchanges including Raydium, Orca, Jupiter, and Serum, enabling comprehensive market coverage for token projects. The platform's Solana volume bot technology utilizes a multi-wallet architecture that distributes trading activity across numerous addresses. This approach allows the Solana volume booster to create varied transaction patterns with different order sizes and timing intervals. The system processes all transactions through the Solana library, ensuring compatibility with the blockchain's high-speed infrastructure. Token projects can activate the Solana volume bot service immediately through the Telegram interface. After accessing the Boost Legends Volume Bot and using the /start command, users enter their token's contract address to begin automated operations. The Solana volume booster then initiates trading activity based on pre-configured algorithmic parameters. Market Applications and Industry Context Trading volume generation has become an essential consideration for cryptocurrency projects operating on the Solana blockchain. The Boost Legends Solana volume bot provides automated solutions for projects seeking to maintain consistent market activity. Many Solana-based tokens utilize automated trading systems to establish initial market presence and maintain visibility on tracking platforms. The launch of this Solana volume booster comes as the Solana ecosystem continues experiencing substantial growth. Daily trading volumes across Solana's decentralized exchange infrastructure regularly exceed billions of dollars, creating a competitive environment where consistent trading activity becomes crucial for project visibility. The Solana volume bot platform addresses these market dynamics by providing accessible automation tools. Comprehensive Features of the Solana Volume Booster System Boost Legends Volume Bot has integrated multiple advanced features into its Solana volume bot platform. The system incorporates intelligent order routing that distributes trades across different DEXs, preventing concentration on any single platform. The Solana volume booster also includes customizable trading parameters that allow projects to adjust volume generation according to their specific requirements. The Solana volume bot employs variable order sizing mechanisms that create diverse trading patterns. Transaction amounts vary within configured ranges, while timing intervals between trades adjust based on algorithmic calculations. This approach enables the Solana volume booster to generate trading activity that appears varied and distributed across different time periods. Security remains a primary focus for the platform. The Solana volume bot operates on a completely non-custodial basis, ensuring users maintain full control of their private keys and funds throughout all operations. Smart contracts utilized by the Solana volume booster have undergone comprehensive security auditing to ensure safe operation. Implementation Process and User Access Projects can begin using the Solana volume bot immediately through the streamlined Telegram interface. The Boost Legends Volume Bot provides comprehensive instructions within the platform, guiding users through the configuration process. Once activated, the Solana volume booster begins executing trades automatically according to the established parameters. The platform's Solana volume bot technology handles all technical complexity behind the scenes. Users do not need extensive technical knowledge to operate the system effectively. The Solana volume booster manages wallet creation, fund distribution, transaction execution, and DEX interactions automatically, simplifying the entire process for token projects. Service Tiers and Pricing Structure Boost Legends Volume Bot offers multiple service levels for its Solana volume bot platform, accommodating projects of various sizes and requirements. The starter tier provides essential Solana volume booster functionality for new tokens entering the market. Growth and enterprise tiers include expanded features and higher volume capabilities for established projects. All service tiers include core Solana volume bot features such as multi-DEX trading, customizable parameters, and 24/7 automated operation. The Solana volume booster platform maintains consistent performance across all service levels, with differences primarily in volume limits and advanced configuration options. Performance Metrics and Platform Capabilities The Boost Legends Solana volume bot demonstrates significant technical capabilities in automated trading execution. The platform can process hundreds of transactions per minute across multiple wallets, leveraging Solana's high-speed blockchain infrastructure. The Solana volume booster maintains 99.9% uptime through redundant systems and automatic failover mechanisms. Transaction cost optimization represents another key feature of the Solana volume bot platform. The system's algorithms minimize gas fees while maintaining effective trading patterns. This efficiency allows the Solana volume booster to generate substantial trading volume while keeping operational costs manageable for projects. Future Development Roadmap Boost Legends Volume Bot has outlined an extensive development roadmap for enhancing the Solana volume bot platform throughout 2025 and beyond. Planned improvements include integration with additional Solana DEXs as they launch, expanding the Solana volume booster system's market coverage. The company plans to implement machine learning algorithms that will enhance the Solana volume bot platform's pattern generation capabilities. These AI-driven improvements will allow the Solana volume booster to adapt trading strategies based on market conditions and optimize performance automatically. Cross-chain functionality represents another significant development priority. Future versions of the Solana volume bot will support multi-blockchain operations, enabling projects to generate volume across different networks. This expansion will position the Solana volume booster as a comprehensive solution for projects operating across multiple blockchain ecosystems. Industry Impact and Market Position The launch of the Boost Legends Solana volume bot represents a notable development in the automated trading sector. As more projects recognize the importance of consistent trading volume for market visibility, platforms like this Solana volume booster become increasingly relevant to the ecosystem's growth. The Solana volume bot joins a growing category of automation tools designed to help cryptocurrency projects establish market presence. By focusing specifically on the Solana blockchain, the Solana volume booster addresses the unique requirements and opportunities within this high-performance ecosystem. About Boost Legends Volume Bot Boost Legends Volume Bot is a blockchain technology company specializing in automated trading solutions for the Solana ecosystem. Founded by experienced DeFi developers and blockchain engineers, the company focuses on creating tools that help cryptocurrency projects establish and maintain market presence through advanced Solana volume bot technology. The company's flagship product, the Boost Legends Solana volume booster, represents years of development and optimization for the Solana blockchain. Based in Miami, Florida, Boost Legends Volume Bot serves a global client base through its online platforms and automated systems. The company remains committed to advancing automated trading technology while maintaining the highest standards of security and reliability. For more information about the Solana volume bot platform or to access the Boost Legends Solana volume booster, interested parties can contact the company through the information provided below. Media Contact Organization: Solana Volume Bot L.L.C Contact Person Name: Paul Feeney Website: Email: [email protected] Contact Number: +14803489692 Address: 148 Bartoletti Route Suite 075 City: West Stacyville State: New Jersey Country: United States SOURCE: Solana Volume Bot L.L.C press release

MIRA Reports Potent Inflammatory Pain Relief from Non-Psychoactive Marijuana Analog Mira-55 in Animal Model, Matching Morphine Without Opioid Risks
MIRA Reports Potent Inflammatory Pain Relief from Non-Psychoactive Marijuana Analog Mira-55 in Animal Model, Matching Morphine Without Opioid Risks

Miami Herald

timea day ago

  • Miami Herald

MIRA Reports Potent Inflammatory Pain Relief from Non-Psychoactive Marijuana Analog Mira-55 in Animal Model, Matching Morphine Without Opioid Risks

With Mira-55 and Ketamir-2, MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / July 3, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced positive preclinical data demonstrating that Mira-55, the Company's proprietary non-psychotropic marijuana analog, delivered morphine-comparable pain relief in a validated model of inflammatory pain-without causing local inflammation. Mira-55 is a next-generation analog of marijuana, engineered to selectively activate CB2 cannabinoid receptors, which are associated with anti-inflammatory and analgesic effects. Unlike THC, Mira-55 minimizes activation of CB1 receptors, reducing the risk of euphoria, sedation, and pro-inflammatory side effects. "These results reinforce the value of Mira-55 as a differentiated cannabinoid-based therapy with real clinical potential," said Erez Aminov, Chairman and CEO of MIRA. "We believe the drug's ability to match morphine's pain relief-without the baggage of addiction, sedation, or THC-like effects-makes Mira-55 an ideal candidate for large, underserved inflammatory pain markets. It's another step in building a non-opioid pain franchise that addresses both inflammatory and neuropathic pain." Study Overview and Key Findings Mira-55 was tested using the formalin model, a gold-standard preclinical method for studying inflammatory pain. In this model, formalin is injected into the rat's paw, producing a pain response that mimics human inflammatory pain. Pain sensitivity was assessed using Von Frey Filament testing, which measures tactile pain thresholds, and inflammation was measured by paw edema volume. Key findings: Mira-55 reduced pain sensitivity by approximately threefold, restoring thresholds to near-baseline analgesic effect was equivalent to morphine, the standard opioid comparator in the sedation or inflammatory swelling was observed with Mira-55 treatment. Importantly, following a scientific review, the U.S. Drug Enforcement Administration (DEA) determined that Mira-55 is not classified as a controlled substance. This designation supports the compound's long-term clinical and commercial viability and removes key barriers typically associated with cannabinoid-based drug development. These results build on prior data from a separate inflammatory pain model conducted by a leading U.S. academic research center, where Mira-55 blocked both thermal and mechanical hyperalgesia without increasing inflammation. In contrast, low-dose THC in that model exacerbated inflammation-further validating Mira-55's selective pharmacological profile. "Mira-55 offers the pain-relieving potential of cannabinoids without the liabilities traditionally seen in THC-based drugs," said Dr. Itzchak Angel, Chief Scientific Advisor at MIRA. "Its novel structure and unique profile with CB2 selectivity and non-scheduled DEA status make it a compelling candidate for treating inflammation-driven pain conditions that are poorly managed by today's standards." Strategic Fit Within MIRA's Pain Portfolio Mira-55 complements Ketamir-2, MIRA's clinical-stage NMDA receptor antagonist, which is advancing through Phase 1 development for neuropathic pain. While Ketamir-2 addresses nerve-related pain through central mechanisms, Mira-55 targets inflammatory pain through the endocannabinoid system. Together, they represent two mechanistically distinct, non-opioid approaches to treating chronic pain. "With Mira-55 and Ketamir-2, we now have two highly differentiated drug candidates with the potential to transform how inflammatory and neuropathic conditions are treated," added Aminov. "We're advancing each asset methodically, and we're energized by the momentum we've built across the pipeline." Corporate Update on SKNY Merger MIRA also announced continued progress on its previously disclosed acquisition of SKNY Pharmaceuticals, the developer of SKNY-1, a novel investigational therapy targeting both obesity and nicotine addiction. In recent studies, SKNY-1 demonstrated a 30% reduction in body weight without muscle loss, along with a reversal of nicotine cravings-highlighting its potential as a differentiated treatment in two major markets. The U.S. Securities and Exchange Commission (SEC) has completed its review of the merger proxy with no comments, allowing MIRA to proceed with shareholder approval and the final steps toward completing the transaction. "We are pleased to report that the SEC had no comments on our merger filing, which reflects the quality of our regulatory and business preparation," said Aminov. "This milestone allows us to advance toward shareholder approval with clarity and confidence as we prepare for the next phase of growth." Next Steps MIRA Pharmaceuticals is advancing Mira-55 toward an Investigational New Drug (IND) submission, with ongoing activities supporting future clinical development in inflammatory pain. The Company remains focused on progressing both lead programs-Mira-55 and Ketamir-2-toward their next regulatory and clinical milestones. About MIRA Pharmaceuticals, Pharmaceuticals, Inc. (NASDAQ:MIRA) is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for neurologic, neuropsychiatric, and metabolic disorders. The Company's pipeline includes oral drug candidates designed to address significant unmet medical needs in areas such as neuropathic pain, inflammatory pain, obesity, addiction, anxiety, and cognitive decline. Cautionary Note Regarding Forward-Looking StatementsThis press release and the statements of MIRA's management related thereto contain "forward-looking statements," which are statements other than historical facts made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may be identified by words such as "aims," "anticipates," "believes," "could," "estimates," "expects," "forecasts," "goal," "intends," "may," "plans," "possible," "potential," "seeks," "will," and variations of these words or similar expressions that are intended to identify forward-looking statements. Any statements in this press release that are not historical facts may be deemed forward-looking. Any forward-looking statements in this press release are based on MIRA's current expectations, estimates, and projections only as of the date of this release and are subject to a number of risks and uncertainties (many of which are beyond MIRA's control) that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements, including related to MIRA's potential merger with SKNY Pharmaceuticals, Inc. These and other risks concerning MIRA's programs and operations are described in additional detail in the Annual Report on Form 10-K for the year ended December 31, 2024, and the Form 14A filed by MIRA on June 18, 2025, and other SEC filings, which are on file with the SEC at and on MIRA's website at MIRA explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law. Contact:Helga Moyainfo@ 432-9792 SOURCE: MIRA Pharmaceuticals

CMG Financial's Courtney Thompson and Susan Walker Named 2025 HousingWire Women of Influence
CMG Financial's Courtney Thompson and Susan Walker Named 2025 HousingWire Women of Influence

Miami Herald

timea day ago

  • Miami Herald

CMG Financial's Courtney Thompson and Susan Walker Named 2025 HousingWire Women of Influence

SAN RAMON, CA / ACCESS Newswire / July 2, 2025 / CMG Financial, one of the nation's top mortgage lenders, is proud to announce that two of its Executive Vice Presidents, Courtney Thompson and Susan Walker, have been named to HousingWire's 2025 Women of Influence list. This prestigious award honors women in housing who are making notable contributions to both their organizations and the industry at large. With their innovative thinking, leadership, and vision for the future, Courtney and Susan exemplify what it means to lead with impact. "This year's honorees include mentors, innovators, and community leaders," wrote Lesley Collins, HousingWire Editor's Choice Awards Program Manager. "Many are paving the way for future generations through mentorship, volunteer initiatives, and by serving on boards that influence key industry practices. Collectively, their efforts are shaping not only their companies but also the communities they serve and the future of housing itself." Courtney Thompson, EVP of Servicing at CMG, has spent the past year tackling one of the biggest challenges in mortgage servicing: building a modern, borrower-first platform from the ground up. Tasked with developing a fully in-house servicing solution, she's led a bold effort to move beyond outdated legacy systems and create something built for today's consumer. Under her leadership, the platform has taken shape as a fully connected ecosystem-one that keeps loan officers involved post-close, gives borrowers access to personalized tools and insights, and reshapes how homeowners interact with their loans. It's not just a tech project-it's a reinvention of the servicing experience, and it's already drawing attention across the industry. Susan Walker, EVP of Corporate Efficiency at CMG, has spent the past year acting as the voice of the loan officer, translating feedback from top performers into meaningful enhancements to CMG's core platforms, CLEAR and Byte. By embedding herself directly with Product and Technology teams, she helped identify workflow inefficiencies and delivered rapid-fire improvements that drove adoption, boosted morale, and aided in bolstering these systems into competitive strengths. Her impact earned her a seat on the Executive Management Team, where she now oversees Post Closing, Vendor Management, and Product. In this new role, she continues to lead with the same hands-on, cross-functional approach, streamlining operations, reducing costs, and identifying upstream efficiency and alignment opportunities. Her results speak volumes: a West Division that topped $3B in volume, over 100 strategic hires, and a culture that now embraces technology more than ever before. Susan's work isn't just about optimizing systems, it's about building a smarter, more resilient CMG. "Courtney and Susan are both exceptional leaders and trusted partners who bring passion, clarity, and a deep sense of responsibility to everything they do," said Paul Akinmade, Chief Strategy Officer at CMG Financial. "They care deeply about their work, their teams, and the future of this company. What stands out is how they bring people together to drive meaningful change, from the first moments of origination all the way through to servicing." CMG congratulates both honorees and thanks HousingWire for recognizing the leadership, excellence, and trailblazing impact of women across housing finance. To read their full Women of Influence profiles, click here. About CMG CMG Mortgage, Inc. NMLS ID# 1820 ( ) is a well-capitalized mortgage lender founded in 1993. Founder and CEO, Christopher M. George, was Chairman of the Mortgage Bankers Association in 2019. CMG makes its products and services available to the market through three distinct origination channels including retail lending, wholesale lending, and correspondent lending. CMG currently operates in all states, including the District of Columbia, and holds approvals with FNMA, FHLMC, and GNMA. CMG is widely known throughout the mortgage banking and housing markets for responsible lending practices, industry and consumer advocacy, product innovation, and operational efficiency. About HousingWire HousingWire is the most influential source of news and information for the U.S. mortgage and housing markets, boasting a readership that spans lending, servicing, investments, and real estate market participants, as well as financial market professionals. With over 10 million annual unique visitors, HousingWire is the community for mortgage and housing professionals to engage and connect. Industry decision-makers rely on us to Move Markets Forward. Media Contact Annaugh MadsenPhone: (667) 260-6360Email: amadsen@ SOURCE: CMG Financial press release

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store